Short sellers are building sizable bets against SpaceX ahead of the company’s upcoming earnings report, even as a newly announced mega deal draws fresh attention to the aerospace giant and its investor base braces for a share-lockup expiration.
The convergence of a major commercial agreement, rising bearish positioning, and the impending end of insider trading restrictions has placed the company at the center of intense market scrutiny in the run-up to its financial results.
The lockup expiration is a key catalyst for traders, as it clears the way for early investors and insiders to sell shares that had previously been restricted. Such events can trigger heightened volatility, and the anticipated flood of newly tradable stock appears to have encouraged some investors to position for downside.
At the same time, the newly unveiled deal has turned heads across the market, underscoring SpaceX’s continued expansion of its commercial footprint. The timing, just before earnings, has sharpened the debate between bulls who point to the company’s growing revenue streams and skeptics wary of stretched valuations.
The dueling narratives echo pressures seen elsewhere in the orbit of founder Elon Musk. SpaceX shares have already come under strain in recent weeks, with the stock touching new lows as an insider selling window drew nearer.
SpaceX has spent recent months preparing for a potential public listing, a move that would rank among the largest market debuts on record. That backdrop has amplified interest in how the company performs and how its shares trade as restrictions ease.
Short interest tends to rise around earnings and lockup events, when uncertainty is elevated and price swings are more likely. Whether the bearish wagers pay off will hinge on the strength of the company’s results and how investors interpret the flood of newly available shares.
The earnings report is expected to offer a clearer picture of SpaceX’s financial trajectory, including revenue from its satellite internet business and launch operations. For now, the company remains a focal point for both optimism over its commercial momentum and caution over near-term trading dynamics.